Alpha 2.0
Login Register
» Articles » PMID: 28924475

Pandemics, Public Health Emergencies and Antimicrobial Resistance - Putting the Threat in an Epidemiologic and Risk Analysis Context

Overview
Journal Arch Public Health
Publisher Biomed Central
Date 2017 Sep 20
PMID 28924475
Citations 23
Authors
C Raina MacIntyre
Chau Minh Bui
Affiliations
Soon will be listed here.
Abstract

Public health messaging about antimicrobial resistance (AMR) sometimes conveys the problem as an epidemic. We outline why AMR is a serious endemic problem manifested in hospital and community-acquired infections. AMR is not an epidemic condition, but may complicate epidemics, which are characterised by sudden societal impact due to rapid rise in cases over a short timescale. Influenza, which causes direct viral effects, or secondary bacterial complications is the most likely cause of an epidemic or pandemic where AMR may be a problem. We discuss other possible causes of a pandemic with AMR, and present a risk assessment formula to estimate the impact of AMR during a pandemic. Finally, we flag the potential impact of genetic engineering of pathogens on global risk and how this could radically change the epidemiology of AMR as we know it. Understanding the epidemiology of AMR is key to successfully addressing the problem. AMR is an endemic condition but can play a role in epidemics or pandemics, and we present a risk analysis method for assessing the impact of AMR in a pandemic.

Citing Articles

Characterization of ES10 lytic bacteriophage isolated from hospital waste against multidrug-resistant uropathogenic .

Nawaz A, Zafar S, Alessa A, Khalid N, Shahzadi M, Majid A Front Microbiol. 2024; 15:1320974.

PMID: 38525078 PMC: 10957765. DOI: 10.3389/fmicb.2024.1320974.

A South African Perspective on the Microbiological and Chemical Quality of Meat: Plausible Public Health Implications.

Manyi-Loh C, Lues R Microorganisms. 2023; 11(10).

PMID: 37894142 PMC: 10608972. DOI: 10.3390/microorganisms11102484.

Preventing the next pandemic: Use of artificial intelligence for epidemic monitoring and alerts.

MacIntyre C, Lim S, Quigley A Cell Rep Med. 2022; 3(12):100867.

PMID: 36543103 PMC: 9798013. DOI: 10.1016/j.xcrm.2022.100867.

Medicinal plants used for the management of respiratory diseases in Zimbabwe: Review and perspectives potential management of COVID-19.

Nyagumbo E, Pote W, Shopo B, Nyirenda T, Chagonda I, Mapaya R Phys Chem Earth (2002). 2022; 128:103232.

PMID: 36161239 PMC: 9489988. DOI: 10.1016/j.pce.2022.103232.

Evaluating UK Pharmacy Workers' Knowledge, Attitudes and Behaviour towards Antimicrobial Stewardship and Assessing the Impact of Training in Community Pharmacy.

Seaton D, Ashiru-Oredope D, Charlesworth J, Gemmell I, Harrison R Pharmacy (Basel). 2022; 10(4).

PMID: 36005938 PMC: 9414432. DOI: 10.3390/pharmacy10040098.

References
1.
de Kraker M, Stewardson A, Harbarth S . Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050?. PLoS Med. 2016; 13(11):e1002184. PMC: 5127510. DOI: 10.1371/journal.pmed.1002184. View
2.
Hageman J, Uyeki T, Francis J, Jernigan D, Wheeler J, Bridges C . Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis. 2006; 12(6):894-9. PMC: 3373026. DOI: 10.3201/eid1206.051141. View
3.
Randolph A, Vaughn F, Sullivan R, Rubinson L, Thompson B, Yoon G . Critically ill children during the 2009-2010 influenza pandemic in the United States. Pediatrics. 2011; 128(6):e1450-8. PMC: 3387899. DOI: 10.1542/peds.2011-0774. View
4.
MacIntyre C . Biopreparedness in the Age of Genetically Engineered Pathogens and Open Access Science: An Urgent Need for a Paradigm Shift. Mil Med. 2015; 180(9):943-9. PMC: 7107569. DOI: 10.7205/MILMED-D-14-00482. View
5.
Joseph C, Togawa Y, Shindo N . Bacterial and viral infections associated with influenza. Influenza Other Respir Viruses. 2013; 7 Suppl 2:105-113. PMC: 5909385. DOI: 10.1111/irv.12089. View